194 related articles for article (PubMed ID: 36480259)
1. The Risk Factors for Cervical Cytological Abnormalities Among Women Infected With Non-16/18 High-Risk Human Papillomavirus: Cross-sectional Study.
Xiao T; Ou CQ; Yang J; Wang C; Yang M; Yu T; Shen L; Xu X; Xing H
JMIR Public Health Surveill; 2022 Dec; 8(12):e38628. PubMed ID: 36480259
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.
Zhang J; Zhao Y; Dai Y; Dang L; Ma L; Yang C; Li Y; Kong L; Wei L; Zhang S; Liu J; Xi M; Chen L; Duan X; Xiao Q; Abulizi G; Zhang G; Hong Y; Gao X; Zhou Q; Xie X; Li L; Niyazi M; Zhang Z; Tuo J; Ding Y; Si M; Chen F; Song L; Qiao Y; Lang J
JAMA Oncol; 2021 Feb; 7(2):263-270. PubMed ID: 33377903
[TBL] [Abstract][Full Text] [Related]
4. Changes in High-Risk HPV Infection Prevalence and Associated Factors in Selected Rural Areas of China: A Multicenter Population-Based Study.
Yu YQ; Jiang MY; Dang L; Feng RM; Bangura MS; Chen W; Qiao YL
Front Med (Lausanne); 2022; 9():911367. PubMed ID: 35903319
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
[TBL] [Abstract][Full Text] [Related]
6. Independent risk factors for high-risk human papillomavirus infection among rural women in Shanxi Province, China: a population-based, case-control study.
Shi R; Qi W; Cai J; Zhao M; Wang Z
Arch Gynecol Obstet; 2023 Aug; 308(2):551-559. PubMed ID: 36814027
[TBL] [Abstract][Full Text] [Related]
7. Prevaccination Prevalence of Type-Specific Human Papillomavirus Infection by Grade of Cervical Cytology in Estonia.
Uusküla A; Oja M; Tamm S; Tisler A; Laanpere M; Padrik L; Nygard M; Reisberg S; Vilo J; Kolde R
JAMA Netw Open; 2023 Feb; 6(2):e2254075. PubMed ID: 36745455
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with high-risk human papillomavirus infection and high-grade cervical neoplasia: A population-based study in Paraguay.
Kasamatsu E; Rodríguez Riveros MI; Soilan AM; Ortega M; Mongelós P; Páez M; Castro A; Cristaldo C; Báez FR; Centurión CC; Vester J; Barrios H; Villalba G; Amarilla ML; Giménez G; Caubere E; Hernández ML; Baena A; Almonte M; Herrero R; Mendoza LP;
PLoS One; 2019; 14(6):e0218016. PubMed ID: 31246959
[TBL] [Abstract][Full Text] [Related]
9. Molecular Epidemiology of Human Papillomavirus Infection Among Chinese Women With Cervical Cytological Abnormalities.
Wong EL; Cheung AW; Chen Z; Wong AY; Yeung AC; Yau PS; Chan PK
Front Public Health; 2022; 10():820517. PubMed ID: 35655449
[TBL] [Abstract][Full Text] [Related]
10. Hybrid capture as a tool for cervical lesions screening in HIV-infected women: insights from a Brazilian cohort.
Jalil EM; Luz PM; Quintana M; Friedman RK; Madeira RMDS; Andrade AC; Chicarino J; Moreira RI; Derrico M; Levi JE; Russomano F; Veloso VG; Grinsztejn B
Braz J Infect Dis; 2018; 22(1):16-23. PubMed ID: 29207280
[TBL] [Abstract][Full Text] [Related]
11. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
[TBL] [Abstract][Full Text] [Related]
12. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.
Cotton S; Sharp L; Little J; Cruickshank M; Seth R; Smart L; Duncan I; Harrild K; Neal K; Waugh N;
BJOG; 2010 May; 117(6):645-59. PubMed ID: 20374607
[TBL] [Abstract][Full Text] [Related]
13. HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions.
Ilisiu MB; Hashim D; Andreassen T; Støer NC; Nicula F; Weiderpass E
Ann Glob Health; 2019 Jun; 85(1):. PubMed ID: 31225959
[TBL] [Abstract][Full Text] [Related]
14. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
15. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
16. Primary HPV screening for cervical cancer: Results after two screening rounds in a regional screening program in Finland.
Veijalainen O; Kares S; Kotaniemi-Talonen L; Kujala P; Vuento R; Luukkaala T; Kholová I; Mäenpää J
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):403-409. PubMed ID: 33037625
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged > 30 years in Xinjiang.
Husaiyin S; Han L; Wang L; Ma C; Ainiwaer Z; Rouzi N; Akemujiang M; Simayil H; Aniwa Z; Nurimanguli R; Niyazi M
BMC Cancer; 2018 Nov; 18(1):1162. PubMed ID: 30470207
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program.
Luquain A; Belglaiaa E; Guenat D; Vrecko S; Riethmuller D; Valmary-Degano S; Bedgedjian I; Chouham S; Prétet JL; Mougin C
Prev Med; 2015 Dec; 81():157-62. PubMed ID: 26348451
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital.
Thistle P; Parpia R; Pain D; Lee H; Manasa J; Schnipper LE
JCO Glob Oncol; 2020 Aug; 6():1276-1281. PubMed ID: 32783640
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
